EUVIMED · CrossrefJournal
Molecular Therapy Methods & Clinical Development
ISSN 2329-0501 · Elsevier BV
Latest articles
Functional, sustained recovery of hearing in Otoferlin-deficient mice using DB-OTO, a hair-cell-specific AAV-based gene therapy
Morphological changes induced by buffer exchange during preparation of mRNA-lipid nanoparticles occur in a stepwise manner as pH is elevated
Comparative analysis of cell-specific promoters in AAV9-mediated gene therapy targeting the central nervous system
Biodistribution of AAV1, AAV5, AAV9, and AAVDJ serotypes after intra-cisterna magna delivery in non-human primates
Systemic mRNA-LNP administration in fetuses improves survival in a mouse model of spinal muscular atrophy
Efficient kidney gene transfer and proximal tubule transduction using self-complementary AAV.cc47 vectors
Adeno-associated virus serotype 9 structural heterogeneity and stability characterized by charge detection mass spectrometry
From cold chain to ambient: Benefits, risks, and evidence across cell therapy logistics
Targeted inhibition of ELANE expression using adenine base editing to treat severe congenital neutropenia
AAV2 delivery of the saCas9 gene results in presentation of an HLA-A∗02:01-restricted T cell epitope potent to induce T cell cytotoxicity
Rational design of lipid nanoparticles for enabling gene therapies
Nonclinical strategies and considerations to enable the redosing of gene therapies
AAV8-based gene replacement therapy for hereditary spastic paraplegia type 5
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administration
Engineering chimeric PCSK9 for a vaccine against atherosclerosis
Rapid cochlear gene therapy in adult deaf mice: Vglut3 rescue via AAV8 achieves day-1 hearing restoration
Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager
Enhanced B cell electroporation efficiency via inhibition of DNA-induced apoptosis and pyroptosis with pan-caspase inhibitor
FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy
Perineural delivery of AAV2/9 in non-human primates is a safe and efficient route for gene therapy in Charcot-Marie-Tooth diseases
Beneficial effect of resveratrol on T cell oxidative metabolism and anti-tumor function is conditioned by prior in vivo T cell history
Improved AAV9-based gene therapy design for SURF1-related Leigh syndrome with minimal toxicity
Development and implementation of an LC-MS-based multi-attribute method for adeno-associated virus
Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases
Natural history of preexisting AAV5 antibodies in adults with hemophilia B during the lead-in of the etranacogene dezaparvovec phase 3 study
A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors
Lipid nanoparticles: Composition, formulation, and application
Species-specific gene expression manipulation in humanized livers of chimeric mice via siRNA-encapsulated lipid nanoparticle treatment
Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized mice
Interlaboratory assessment of candidate reference materials for lentiviral vector copy number and integration site measurements
EUVIMED